Publicacións en colaboración con investigadores/as de Complejo Asistencial de Segovia (24)

2024

  1. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. “Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study”

    European Journal of Surgical Oncology, Vol. 49, Núm. 10

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2020

  1. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 3, pp. 267-276

2017

  1. A protective personal factor against disability and dependence in the elderly: an ordinal regression analysis with nine geographically-defined samples from Spain

    BMC Geriatrics, Vol. 17, Núm. 1, pp. 1-10

2016

  1. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: Study protocol for a randomized controlled trial

    Trials, Vol. 17, Núm. 1

2015

  1. Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis

    Critical Care, Vol. 19, Núm. 1

2014

  1. GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: Do we still need alkylators?

    Blood, Vol. 124, Núm. 12, pp. 1887-1893

2012

  1. Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

    Blood, Vol. 120, Núm. 13, pp. 2581-2588

2011

  1. Medical, environmental and personal factors of disability in the elderly in Spain: A screening survey based on the International Classification of Functioning

    Gaceta Sanitaria, Vol. 25, Núm. SUPPL. 2, pp. 29-38

  2. Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain

    Acta Neurologica Scandinavica, Vol. 123, Núm. 5, pp. 316-324

  3. Prevalence of disability in a composite ≥75 year-old population in Spain: A screening survey based on the International Classification of Functioning

    BMC Public Health, Vol. 11

2010

  1. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: A randomised trial

    The Lancet Oncology, Vol. 11, Núm. 10, pp. 934-941

2009

  1. Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC)

    Human Mutation, Vol. 30, Núm. 11, pp. 1558-1566

  2. Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008

    BMC Neurology, Vol. 9, pp. 55

  3. Short daily versus conventional hemodialysis quality of life: A cross-sectional multicentric study in Spain

    Blood Purification, Vol. 28, Núm. 3, pp. 159-164

2007

  1. Validación transcultural de la Escala de Sentido de Coherencia de Antonovsky (OLQ-13) en ancianos mayores de 70 años

    Medicina Clinica, Vol. 128, Núm. 13, pp. 486-492

2006

  1. Stroke prevalence among the Spanish elderly: An analysis based on screening surveys

    BMC Neurology, Vol. 6